Cerner Provides Access to De-Identified Patient Data for COVID-19 Research and Vaccine Development

Cerner Corporation (GLOBE NEWSWIRE)

KANSAS CITY, Mo., April 24, 2020 (GLOBE NEWSWIRE) — Cerner Corporation (Nasdaq: CERN), a global health care technology company, is now offering select U.S. health systems and academic research centers complimentary access to critical de-identified COVID-19 patient data to help fight the pandemic.

This offering will provide eligible health care researchers free access to Cerner’s COVID-19 data set to support epidemiological studies, clinical trials and medical treatments related to COVID-19, in line with applicable laws and guidelines.

The de-identified patient data secured and stored on Cerner HealtheDataLab™, powered by Amazon Web Services Inc. (AWS), will include COVID-19-related demographics to help track spread and surge, underlying illnesses and chronic conditions, treatments, lab results and clinical complications and outcomes that could help drive important medical decisions. […]

Click here to view original web page at www.bakersfield.com